SCHEMBL1388797

SCHEMBL1388797

N#CC(=Cc1ccc2ccccc2c1)C(N)=O

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 1/20 0.66
KDM4E B2RXH2 8/20 0.63
MAPT P10636 6/20 0.63
EGFR P00533 5/20 0.63
ALDH1A1 P00352 4/20 0.63
MEN1 O00255 3/20 0.63
KMT2A Q03164 3/20 0.63
CYP1A2 P05177 2/20 0.63
TDP1 Q9NUW8 2/20 0.63
ERBB2 P04626 2/20 0.63
TP53 P04637 2/20 0.63
LCK P06239 1/20 0.63
HPGD P15428 1/20 0.63
HSD17B10 Q99714 1/20 0.63
NEK2 P51955 3/20 0.59
GAA P10253 3/20 0.56
NPC1 O15118 1/20 0.56
RAB9A P51151 1/20 0.56
POLB P06746 2/20 0.54
APEX1 P27695 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30856935 1.00 MCL1 (0.66) MCL1KDM4EMAPTEGFRALDH1A1
SCHEMBL1388796 1.00 MCL1 (0.66) MCL1KDM4EMAPTEGFRALDH1A1
SCHEMBL20523573 0.86 EGFR (0.62) MCL1KDM4EEGFRALDH1A1ERBB2
SCHEMBL1388545 0.84 MAPT (0.63) MCL1KDM4EMAPTEGFRALDH1A1
SCHEMBL1388543 0.84 MAPT (0.63) MCL1KDM4EMAPTEGFRALDH1A1
SCHEMBL17120687 0.81 MAPT (0.58) MCL1KDM4EMAPTEGFRALDH1A1
SCHEMBL21470204 0.81 ALDH1A1 (0.55) KDM4EMAPTALDH1A1MEN1KMT2A
SCHEMBL11674085 0.80 EGFR (0.46) MCL1KDM4EMAPTEGFRALDH1A1
SCHEMBL1692376 0.80 MCL1 (1.00) MCL1KDM4EMAPTEGFRALDH1A1
SCHEMBL1692375 0.80 MCL1 (1.00) MCL1KDM4EMAPTEGFRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0987263-A2 Arylidene and heteroarylidene oxindole derivatives as tyrosine kinase inhibitors PHARMACIA & UPJOHN S.p.A. (IT) 2000-03-22 EP claimed
JP-H08500847-A 1996-01-30 JP claimed
EP-0658159-A1 ARYLIDENE AND HETEROARYLIDENE OXINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS PHARMACIA & UPJOHN S.p.A. (IT) 1995-06-21 EP claimed
WO-1995001349-A1 ARYLIDENE AND HETEROARYLIDENE OXINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS PHARMACIA S.P.A. (IT) 1995-01-12 WO claimed
CN-117916225-A N-heterocyclyl substituted 2-cyano-3- (naphthalen-2-yl) acrylamide derivatives as fluorophores for detection of amyloid and amyloid-like proteins for diagnosis of neurodegenerative disorders 阿米达斯公司 2024-04-19 CN disclosed
CN-117916225-A N-heterocyclyl substituted 2-cyano-3- (naphthalen-2-yl) acrylamide derivatives as fluorophores for detection of amyloid and amyloid-like proteins for diagnosis of neurodegenerative disorders 阿米达斯公司 2024-04-19 CN disclosed
CN-117916225-A N-heterocyclyl substituted 2-cyano-3- (naphthalen-2-yl) acrylamide derivatives as fluorophores for detection of amyloid and amyloid-like proteins for diagnosis of neurodegenerative disorders 阿米达斯公司 2024-04-19 CN disclosed
EP-0987263-B1 Arylidene and heteroarylidene oxindole derivatives as tyrosine kinase inhibitors PFIZER ITALIA SRL (IT) 2007-04-18 EP disclosed
EP-0987263-A2 Arylidene and heteroarylidene oxindole derivatives as tyrosine kinase inhibitors PHARMACIA & UPJOHN S.p.A. (IT) 2000-03-22 EP disclosed
US-5656654-A TYROSINE KINASE INHIBITORS FARMITALIA CARLO ERBA S.R.L. (IT) 1997-08-12 US disclosed
EP-0558950-B1 3-aryl-glycidic ester derivatives and process for their preparation PHARMACIA SPA (IT) 1996-12-04 EP disclosed
US-5436235-A 3-aryl-glycidic ester derivatives FARMITALIA CARLO ERBA S.R.L. (IT) 1995-07-25 US disclosed
EP-0658159-A1 ARYLIDENE AND HETEROARYLIDENE OXINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS PHARMACIA & UPJOHN S.p.A. (IT) 1995-06-21 EP disclosed
WO-1995001349-A1 ARYLIDENE AND HETEROARYLIDENE OXINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS PHARMACIA S.P.A. (IT) 1995-01-12 WO disclosed
EP-0558950-A1 3-aryl-glycidic ester derivatives and process for their preparation PHARMACIA S.p.A. (IT) 1993-09-08 EP disclosed